查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1967671

细胞冷冻保存市场－全球产业规模、份额、趋势、机会、预测：按产品、应用、地区和竞争对手划分，2021-2031年

Cell Cryopreservation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球细胞冷冻保存市场预计将从 2025 年的 118.4 亿美元成长到 2031 年的 165.4 亿美元，复合年增长率为 5.73%。

这种将生物样本冷却至冰点以下以终止其代谢并确保其未来使用活性的过程，随着再生医学的兴起和生物银行在临床研究中的关键作用而不断发展。此外，生物製药研发的持续投入也推动了市场的长期扩张，因为人们对可靠保存复杂细胞产品的需求日益增长。

市场概览
预测期 2027-2031
市场规模：2025年 118.4亿美元
市场规模：2031年 165.4亿美元
复合年增长率：2026-2031年 5.73%
成长最快的细分市场 细胞冻存液
最大的市场 北美洲

儘管取得了这些进展，低温运输基础设施所需的巨额资本和营运成本仍然是重大障碍，限制了其快速扩充性。此外，研发过程中需要可靠储存的候选治疗药物数量不断增加，进一步加剧了这些成本。根据再生医学联盟的数据，2024年全球共有2,406项细胞和基因疗法临床试验正在进行中。虽然如此庞大的数量表明市场需求强劲，但储存如此大量的生物材料所带来的复杂财务挑战仍然阻碍着高效的供应链管理。

市场驱动因素

再生医学和细胞治疗领域的快速发展正在推动市场成长，因为这需要强大的低温运输基础设施。随着基因编辑疗法从临床试验走向商业市场，对分散式储存设施的需求日益增长，而旨在加速产品研发的大规模产业投资也推动了这一趋势。 2024年10月，再生医学联盟报告称，该领域在上半年已筹集了109亿美元的资金筹措。随后，各公司正在建立广泛的治疗网络。例如，2025年2月，Vertex Pharmaceuticals宣布，到2024年底，该公司已在全球建立了50多个认证的治疗中心，凸显了冷冻保存技术在维持其自主研发产品活性的重要性。

此外，不孕症的增加和辅助生殖技术（ART）需求的成长正显着推动市场成长，因为现代生殖医学高度依赖生物样本的玻璃化和冷冻保存。该行业正经历着向「全冷冻保存」策略和选择性生育治疗保存的重大转变，从而催生了对长期储存能力的需求。 2025年4月，辅助生殖技术协会（SART）报告称，其成员诊所在2023年进行了432,641个体外受精（IVF）週期。手术量的激增直接推动了对用于长期保存精子、卵子和胚胎的先进冷冻保存培养基和自动化储存解决方案的需求。

市场挑战

建造和维护低温运输基础设施所需的巨额资本和营运成本是细胞冷冻保存市场成长的主要障碍。建立可靠的储存设施需要前期投资大量资金，用于购买专用冷冻库、自动化监控系统和备用电源系统，以确保样品安全。除了这些初始成本外，持续的液态氮采购、设备维护以及遵守严格的法规也给储存服务提供者和生物製药研发公司带来了持续的财务负担。

整个研发过程中需要安全长期储存的大量生物材料进一步加剧了这项财务负担。随着治疗产品线的扩展，保存这些珍贵材料的总成本不断上升，往往会对规模小规模的研发公司造成沉重的预算压力。 2024年，美国基因与细胞治疗学会（ASGCT）报告称，全球共有4021种基因、细胞和RNA疗法处于不同的开发平臺阶段。管理如此庞大的研发资产的储存物流需要大量资金，这实际上限制了市场高效扩张的能力。

市场趋势

在生物银行工作流程中，机器人自动化正被日益广泛地应用于样本管理，以减少人为接触并确保处理过程中的温度稳定性。为了提高效率并减少错误，各机构正在部署自动化检索系统，将样本储存在超低温环境中，避免人工操作和温度波动。这一趋势体现在对先进管理基础设施投资的增加。 Azenta Life Sciences 在 2025 年 5 月发布的报告显示，其样本管理解决方案在 2025 财年第二季度的收入达到 8000 万美元，同比增长 8%，这主要得益于市场对自动化存储和临床样本服务的强劲需求。

同时，为了满足细胞和基因疗法严格的监管要求，符合GMP规范的即用型冷冻保存培养基正成为市场趋势。研发人员正逐步抛弃传统的血清基培养基和自製培养基，转而选择化学成分明确的培养基，以提高批间一致性并降低毒性风险。随着商业治疗方法生产的扩大，这些最佳化工具的应用正在加速。 2025年5月，BioLife Solutions宣布其细胞处理收入已达2,160万美元，年增33%。这主要归功于其GMP级培养基被整合到17种已通过核准的商业化治疗方法的生产中。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球细胞冷冻保存市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 产品类别（细胞冻存培养基、设备、耗材）
    • 依应用（干细胞、卵子/胚胎细胞、精子细胞、肝细胞等）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美细胞冷冻保存市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲细胞冷冻保存市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区细胞冷冻保存市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲细胞冷冻保存市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美细胞冷冻保存市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球细胞冷冻保存市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Thermo Fisher Scientific Inc.
  • PromoCell GmbH
  • Merck KGaA
  • Sartorius AG
  • Lonza Group Ltd.
  • Corning Incorporated
  • Creative Biolabs
  • BioLife Solutions Inc.
  • Danaher Corporation
  • HiMedia Laboratories Pvt. Ltd

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 24284

The Global Cell Cryopreservation Market is projected to expand from USD 11.84 Billion in 2025 to USD 16.54 Billion by 2031, reflecting a compound annual growth rate of 5.73%. This process, which entails cooling biological specimens to sub-zero temperatures to halt metabolism and ensure viability for later use, is growing due to the rise of regenerative medicine and the critical role of biobanking in clinical studies. Furthermore, continued funding for biopharmaceutical research and development underpins long-term market expansion by creating a need for dependable storage for increasingly sophisticated cellular products.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 11.84 Billion
Market Size 2031USD 16.54 Billion
CAGR 2026-20315.73%
Fastest Growing SegmentCell Freezing Media
Largest MarketNorth America

Despite these advancements, significant barriers exist regarding the substantial capital and operating costs needed for cold chain infrastructure, limiting rapid scalability. The burden of these expenses is magnified by the increasing quantity of therapeutic candidates requiring reliable preservation during development. Data from the Alliance for Regenerative Medicine indicates that 2,406 clinical trials for cell and gene therapies were active globally in 2024. Although this high volume suggests robust demand, the financial intricacies involved in storing such a large amount of biological material continue to impede efficient supply chain management.

Market Driver

The rapid growth of the regenerative medicine and cell therapy sectors propels the market by demanding strong cold chain infrastructure. As gene-edited treatments move from clinical trials to the commercial market, there is a growing need for decentralized preservation facilities, a trend bolstered by significant industry investment aimed at speeding up pipeline development. The Alliance for Regenerative Medicine reported in October 2024 that the sector secured $10.9 billion in the first half of the year. Consequently, companies are building vast treatment networks; for instance, Vertex Pharmaceuticals noted in February 2025 that it had established over 50 authorized treatment centers worldwide by the end of 2024, highlighting the reliance on cryopreservation for maintaining autologous product viability.

Additionally, the rising prevalence of infertility and the demand for Assisted Reproductive Technologies (ART) significantly boost market growth, as modern fertility procedures rely heavily on the vitrification of biological samples. There is a notable industry shift toward "freeze-all" strategies and elective fertility preservation, necessitating long-term storage capabilities. In April 2025, the Society for Assisted Reproductive Technology reported that member clinics performed 432,641 IVF cycles in 2023. This increase in procedure volume directly drives the need for sophisticated cryopreservation media and automated storage solutions to preserve gametes and embryos over long periods.

Market Challenge

The substantial capital and operational costs required to build and sustain cold chain infrastructure represent a major obstacle to the growth of the cell cryopreservation market. Setting up reliable storage facilities demands heavy upfront investment in specialized freezers, automated monitoring, and backup power systems to guarantee sample safety. Beyond these initial expenditures, ongoing costs for liquid nitrogen, equipment upkeep, and adherence to strict regulations impose a continuous financial burden on preservation providers and biopharmaceutical developers.

This economic strain is worsened by the massive volume of biological materials needing secure, long-term storage throughout the development process. As the therapeutic pipeline grows, the total cost of preserving these delicate materials rises, often straining the budgets of smaller development companies. The American Society of Gene & Cell Therapy noted in 2024 that the global pipeline contained 4,021 gene, cell, and RNA therapies across various stages. Managing the storage logistics for such a vast array of developmental assets necessitates significant capital, effectively limiting the market's ability to scale operations efficiently.

Market Trends

Biobanking workflows are increasingly incorporating robotic automation to transform sample management, reducing human contact and ensuring stable temperatures during handling. To enhance efficiency and decrease errors, facilities are adopting automated retrieval systems that keep samples at ultra-low temperatures without the fluctuations caused by manual access. This trend is reflected in rising investments in advanced management infrastructure; Azenta Life Sciences reported in May 2025 that its Sample Management Solutions revenue hit $80 million in the second quarter of fiscal 2025, an 8% rise driven by strong demand for automated storage and clinical sample services.

Concurrently, there is a significant shift toward using ready-to-use, GMP-compliant cryopreservation media to satisfy rigorous regulatory requirements for cell and gene therapies. Developers are abandoning traditional serum-based or homemade formulations in favor of chemically defined options that provide better consistency between lots and lower toxicity risks. The uptake of these optimized tools is speeding up as commercial therapies expand manufacturing; BioLife Solutions announced in May 2025 that its cell processing revenue grew 33% year-over-year to $21.6 million, largely due to the integration of its GMP-grade media into the production of 17 approved commercial therapies.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • PromoCell GmbH
  • Merck KGaA
  • Sartorius AG
  • Lonza Group Ltd.
  • Corning Incorporated
  • Creative Biolabs
  • BioLife Solutions Inc.
  • Danaher Corporation
  • HiMedia Laboratories Pvt. Ltd

Report Scope

In this report, the Global Cell Cryopreservation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Cryopreservation Market, By Product

  • Cell Freezing Media
  • Equipment
  • Consumables

Cell Cryopreservation Market, By Application

  • Stem Cells
  • Oocytes and Embryotic Cells
  • Sperm Cells
  • Hepatocytes
  • Others

Cell Cryopreservation Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Cryopreservation Market.

Available Customizations:

Global Cell Cryopreservation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Cryopreservation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Cell Freezing Media, Equipment, Consumables)
    • 5.2.2. By Application (Stem Cells, Oocytes and Embryotic Cells, Sperm Cells, Hepatocytes, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Cell Cryopreservation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cell Cryopreservation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Cell Cryopreservation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Cell Cryopreservation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe Cell Cryopreservation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cell Cryopreservation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. France Cell Cryopreservation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Cell Cryopreservation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Cell Cryopreservation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Cell Cryopreservation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia Pacific Cell Cryopreservation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cell Cryopreservation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. India Cell Cryopreservation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Cell Cryopreservation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Cell Cryopreservation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Cell Cryopreservation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. Middle East & Africa Cell Cryopreservation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cell Cryopreservation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Cell Cryopreservation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Cell Cryopreservation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. South America Cell Cryopreservation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cell Cryopreservation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Cell Cryopreservation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Cell Cryopreservation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cell Cryopreservation Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. PromoCell GmbH
  • 15.3. Merck KGaA
  • 15.4. Sartorius AG
  • 15.5. Lonza Group Ltd.
  • 15.6. Corning Incorporated
  • 15.7. Creative Biolabs
  • 15.8. BioLife Solutions Inc.
  • 15.9. Danaher Corporation
  • 15.10. HiMedia Laboratories Pvt. Ltd

16. Strategic Recommendations

17. About Us & Disclaimer